It appears to protect kidney function by improving blood glucose control, reducing inflammation, and potentially lessening protein loss in urine, which is a key indicator of kidney stress
At 72 weeks, the mean percentage change in weight was -20.9% with 15 mg of tirzepatide, as compared with -3.1% with placebo. SURMOUNT-1, per Jastreboff AM et al
#PriorAuthorizationChecklist #PrescriberSupport #BehavioralHealthCare #CareCoordination To view or add a comment, sign in New GLP-1 Pricing Video - Our latest GLP-1 update breaks down how GLP-1s are integrated into the TrumpRx deal, new Medicare and Medicaid benchmarks, and what PBMs and plan sponsors need to know about GLP-1s for 2026
They show promise in helping with metabolic disorders like type 2 diabetes and metabolic syndrome
Para pacientes con insuficiencia cardaca o enfermedad renal crnica, los inhibidores SGLT2 son generalmente la primera opcin, pero los GLP-1 pueden considerarse cuando los SGLT2 no son adecuados o como terapia complementaria
Your Weight Loss Goals: Setting realistic and achievable weight loss targets